Status:
COMPLETED
Palliative Care in Improving Quality of Life in Patients With Newly Diagnosed Pancreatic Cancer
Lead Sponsor:
City of Hope Medical Center
Collaborating Sponsors:
National Cancer Institute (NCI)
National Institute of Nursing Research (NINR)
Conditions:
Stage IIA Pancreatic Cancer
Stage IIB Pancreatic Cancer
Eligibility:
All Genders
21+ years
Phase:
NA
Brief Summary
This pilot clinical trial studies a palliative care program in improving the quality of life of patients with newly diagnosed pancreatic cancer. Palliative care is care given to patients who have a se...
Detailed Description
PRIMARY OBJECTIVES: I. To pilot-test an interdisciplinary Palliative Care Planning Intervention (PCPI) in pancreatic cancer. Specifically, to describe patients' satisfaction with the timing, content,...
Eligibility Criteria
Inclusion
- Pathologically confirmed, new diagnosis of borderline resectable, locally advanced resectable/unresectable, or metastatic pancreatic cancer
- Patients who are scheduled to receive treatments (neoadjuvant therapy, surgery, adjuvant therapy, or palliative chemotherapy) at City of Hope (COH)
- All subjects must have the ability to understand and the willingness to provide informed consent
Exclusion
- Subjects, who in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study
Key Trial Info
Start Date :
November 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2015
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT02307539
Start Date
November 1 2014
End Date
May 1 2015
Last Update
June 3 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
City of Hope Medical Center
Duarte, California, United States, 91010